Has John Kassotis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $255,838 in general payments to John Kassotis, MD across 264 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Kassotis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Kassotis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Kassotis, MD

Clinical Cardiac Electrophysiology · Riverhead, NYNPI 1598759003

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $179,070 of the $255,838 with a category attached, or 70.0%. 14 manufacturers reported payments, led by Johnson & Johnson at 46.6% of the total. Reporting peaked in 2019 at $85,468 and has fallen 93.2% since, to $5,817 in 2025. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$255,838in general payments, 2019–2025

Across 264 payments — averaging $969.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$119K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$67K
Cvrx, Inc.$46K
AstraZeneca$18K
Altathera Pharmaceuticals LLC$3K
Medtronic$2K
plus $1K from 8 others

$223,827in research payments, 2019–2025

Across 59 payments — averaging $3793.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boehringer Ingelheim$70K
AstraZeneca$67K
Novartis$64K
Medtronic$11K
Cvrx, Inc.$10K
Boehringer Ingelheim Pharma GmbH & Co.kg$2K
plus $361 from 2 others

What the payments were for

Consulting fees$46,27518%
Speaking & faculty fees$179,07070%
Travel & lodging$26,94811%
Food & beverage$3,5401%
Education$50%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	87	$119,093
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	66	$66,919
Cvrx, Inc.	50	$45,714
AstraZeneca	23	$17,989
Altathera Pharmaceuticals LLC	4	$2,577
Medtronic(2 entities)	17	$2,182
ZOLL Respicardia, Inc.	2	$573
Abbott	6	$406
Boston Scientific	2	$197
Baxter Healthcare	3	$79
Impulse Dynamics (USA) Inc.	1	$60
Novo Nordisk	1	$23
E.r. Squibb & Sons, L.L.C.	1	$15
Novartis	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XARELTO$118,311
LifeVest$66,454
Barostim Neo System$45,265
FARXIGA$17,561
Sotalol Hydrochloride$2,574
Micra$1,637
remede System$573
TYRX$350
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$143
AVVIGO Guidance System$139
MitraClip$108
CARDIOMEMS$106

How this compares

$255,838 in reported general payments places this provider in the 90th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$203,725

Medicare patients

765

Services billed

2,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical cardiac electrophysiology in Riverhead

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
Felix YangBrooklyn$407K
James IpNew York$347K
Stavros MountantonakisManhasset$321K
Jorge RomeroSyracuse$295K
Nicholas SkipitarisNew York$293K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →